The Johns Hopkins Institute for NanoBioTechnology has named Thomas Fekete as its new director of corporate partnerships.
Fekete will act as a liaison between INBT faculty researchers and industry representatives, and will work to facilitate technology transfer from INBT-affiliated labs. Prior to joining Johns Hopkins, Fekete most recently worked for KV Pharmaceuticals as director of operations projects. Prior tot hat, he directed manufacturing sites for Astaris and held executive-level positions in research, engineering, and manufacturing for the chemicals operations of FMC Corporation in Baltimore and Philadelphia.
Fekete holds a master's degree in chemical engineering from Johns Hopkins and a bachelor's degree in chemical engineering from Rensselaer Polytechnic Institute.
UW TechTransfer, the commercialization arm of the University of Washington, last week said that it recruited the initial members of two new services under its LaunchPad commercialization program: an Entrepreneur-in-Residence program and an Entrepreneur Advisor program.
UW has recruited the following executives during the initial phase of the Entrepreneur-in-Residence program:
• Alex St. John, a former Microsoft executive and co-inventor of the DirectX gaming platform. St. John also co-founded online gaming network Wild Tangent.
• Deborah Kessler, a former Merck executive and COO of Rosetta Informatics
• Jeff Canin, who has formerly served as an associate at US Venture Partners, a venture capitalist for eFund, an investment banker at Dain Rauscher, and co-founder of the Center for Smart Energy
The first group of Entrepreneur Advisors includes:
• Joe Eichinger, co-founder and president of CoAptus Medical
• Bill Grossman, former CEO of Revenue Science
• John Hansen, former CEO of Vallent
• Michael Hovanes, a medical device and imaging entrepreneur
• Will Poole, a former Microsoft vice president
• Chris Porter, formerly of CellPro and Pfizer
• Sterling Wilson, former president of Qpass and executive at Concur Technologies